Xencor Alternatives & Competitors
12 companies similar to Xencor — Proteins by Design
Pragma Bio
Mining the molecules that matter
South San Francisco, Unit...
InterAx Biotech
Advanced integration of biological systems, math models and artificial intelligence
Switzerland
Ascent Bio
Building the future of molecule intelligence
New Haven, United States
InSilicoTrials
Innovating Life Sciences
Wilmington, United States
Track all Xencor competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Photys Therapeutics
Developing novel bifunctional medicines for fine-tuned control of protein post-translation...
Waltham, United States
Chai Discovery
Building frontier artificial intelligence to predict and reprogram the interactions betwee...
San Francisco, United Sta...
NextRNA Therapeutics
Leading The Next Revolution of RNA-directed Therapeutics
Boston, United States
Tamarind Bio
AI Platform for Computational Molecular Design
San Francisco, United Sta...
Stellanova Therapeutics
Conquering Cancer
Houston, United States
doDOC
Write better, faster, together | Part of Envision Pharma Group
Boston, United States
Adamant Health
Revolutionizing the care of Parkinson’s disease.
Kuopio, Finland
Sentebiolab Biotechnology
Let's synthesize life together...
Ankara, Turkey
About Xencor
Proteins by Design
Design and development of bispecific antibody drugs, Strategic collaborations with pharmaceutical companies, Extensive clinical and preclinical drug pipeline, Customization of antibodies using XmAb protein engineering platform
Pharmaceutical companies interested in drug development partnerships, Investors seeking opportunities in biotechnology and life sciences, Healthcare professionals focused on cancer and serious disease therapeutics, Scientific research communities involved in antibody and protein engineering
Protein Engineering, Antibody Therapeutics, Biotherapeutics, Autoimmune Disease Treatment, Oncology, Asthma Treatment, B Cell Malignancies, Hodgkin's Lymphoma, Myeloma Treatment, Biosuperiors, Monoclonal Antibodies, Bispecific Antibodies, Drug Development, Cytokines, Neuroinflammatory Diseases
B2B, B2B2B, API
Licensing, Performance Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Xencor and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Xencor on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.